These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 3513812

  • 21. Differential expression of HLA-DR and HLA-DC/DS molecules in a patient with hairy cell leukemia: restoration of HLA-DC/DS expression by (12-0-tetradecanoyl phorbol-13-acetate), 5 azacytidine, and sodium butyrate.
    Faille A, Turmel P, Charron DJ.
    Blood; 1984 Jul; 64(1):33-7. PubMed ID: 6203577
    [Abstract] [Full Text] [Related]

  • 22. Ontogenic and functional implications of the differential expression of HLA-DQ antigens on leukemic cells.
    Navarrete C, Fernandez N, Alonso MC, Festenstein H.
    Hum Immunol; 1986 May; 16(1):52-68. PubMed ID: 3519548
    [Abstract] [Full Text] [Related]

  • 23. Induction of MHC class II molecules HLA-DR, -DP and -DQ and ICAM 1 in human podocytes by gamma-interferon.
    Baudeau C, Delarue F, Hé CJ, Nguyen G, Adida C, Peraldi MN, Sraer JD, Rondeau E.
    Exp Nephrol; 1994 May; 2(5):306-12. PubMed ID: 7812737
    [Abstract] [Full Text] [Related]

  • 24. Monoclonal antibody against a membrane antigen characterizing leukemic human B-lymphocytes.
    Forster HK, Gudat FG, Girard MF, Albrecht R, Schmidt J, Ludwig C, Obrecht JP.
    Cancer Res; 1982 May; 42(5):1927-34. PubMed ID: 6175400
    [Abstract] [Full Text] [Related]

  • 25. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY, Sun XF, Yan SL, He LR, Zhen ZJ, Xia Y.
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [Abstract] [Full Text] [Related]

  • 26. The MHC class I associated beta 2-microglobulin (beta 2m) light chain is expressed in a molar excess over HLA-ABC and CD1 on the membrane of leukaemic B cells but not leukaemic T cells: evidence for further beta 2m-associated molecules.
    Jones RA, Child JA, Master PS, Scott CS.
    Scand J Immunol; 1991 Jul; 34(1):53-61. PubMed ID: 1712510
    [Abstract] [Full Text] [Related]

  • 27. Phorbol ester-induced differentiation of chronic B lymphocytic leukaemia cells--regulatory impact of autologous and allogeneic accessory cells.
    Danersund A, Tötterman TH, Nilsson K, Egle-Jansson I, Kabelitz D, Sjöberg O.
    Clin Exp Immunol; 1985 Mar; 59(3):644-52. PubMed ID: 3872753
    [Abstract] [Full Text] [Related]

  • 28. [Determination of leukemic B-lymphoma cells with the monoclonal antibody anti-Y 29/55].
    Obrecht JP, Gudat F, Forster HK, Albrecht R, Girard MF, Ludwig C, Christen C.
    Schweiz Med Wochenschr; 1981 Oct 10; 111(41):1529-31. PubMed ID: 6975994
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Enhanced expression of human Ia antigens by chronic lymphocytic leukemia cells following treatment with 12-O-tetradecanoylphorbol-13-acetate.
    Guy K, Van Heyningen V, Dewar E, Steel CM.
    Eur J Immunol; 1983 Feb 10; 13(2):156-9. PubMed ID: 6403357
    [Abstract] [Full Text] [Related]

  • 33. Monoclonal antibody studies in B(non-T)-cell malignancies.
    Shimoyama M, Minato K, Tobinai K, Nagai M, Hirose M.
    Jpn J Clin Oncol; 1983 Sep 10; 13(3):477-88. PubMed ID: 6417373
    [Abstract] [Full Text] [Related]

  • 34. Reactivity of the monoclonal antibody RFB1 in chronic B-cell leukaemias.
    Melo JV, Catovsky D, Bodger M.
    Scand J Haematol; 1984 Apr 10; 32(4):417-22. PubMed ID: 6609424
    [Abstract] [Full Text] [Related]

  • 35. Use of the monoclonal antibody WR17, identifying the CD37 gp40-45 Kd antigen complex, in the diagnosis of B-lymphoid malignancy.
    Moore K, Cooper SA, Jones DB.
    J Pathol; 1987 May 10; 152(1):13-21. PubMed ID: 3305845
    [Abstract] [Full Text] [Related]

  • 36. A human B lymphocyte antigen (P-76) shared by B-cell chronic lymphocytic leukemia cells and hairy cell leukemia cells.
    Kanakura Y, Machii T, Kurata Y, Tamaki T, Yonezawa T, Tarui S, Kitani T.
    Blut; 1983 May 10; 46(5):249-59. PubMed ID: 6340759
    [Abstract] [Full Text] [Related]

  • 37. Hairy cell leukaemia: effects of phorbol ester on cell morphology and adherence and comparison with other B-cell neoplasias.
    Polliack A, Gurfel D, Or R, Leizerowitz R, Gazitt Y.
    Scand J Haematol; 1986 Apr 10; 36(4):358-66. PubMed ID: 3487109
    [Abstract] [Full Text] [Related]

  • 38. Two monoclonal antibodies defining unique antigenic determinants on human B-lymphoma cells.
    Howard DR, Eaves AC, Takei F.
    Cancer Res; 1985 Dec 10; 45(12 Pt 1):6322-7. PubMed ID: 2415242
    [Abstract] [Full Text] [Related]

  • 39. MHC class II antigen and immunoglobulin expression in spontaneous phenotypic variants of the Burkitt's lymphoma cell line Namalwa.
    Guy K, Middleton PG, Docherty LJ, De Angelis CL, Steel CM.
    Immunology; 1986 Dec 10; 59(4):603-10. PubMed ID: 3026962
    [Abstract] [Full Text] [Related]

  • 40. Immunoglobulin abnormalities in malignant non-Hodgkin's lymphoma.
    Economidou J, Terzoglou K, Anagnostou D, Nikiforakis EM, Papajannis A.
    Scand J Haematol; 1984 Aug 10; 33(2):123-8. PubMed ID: 6433436
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.